AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript May 7, 2024

AbCellera Biologics Inc.  isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good afternoon and welcome to AbCellera’s Q1, 2024 Business Update Conference Call. My name is Harry and I will facilitate the audio portion of today’s interactive broadcast. [Operator Instructions]. At this time, I would like to turn the call over to Tryn...